{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T20:10:58Z","timestamp":1786997458188,"version":"build-2736575974"},"reference-count":168,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thrombosisresearch.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Thrombosis Research"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1016\/j.thromres.2019.07.014","type":"journal-article","created":{"date-parts":[[2019,7,19]],"date-time":"2019-07-19T19:53:27Z","timestamp":1563566007000},"page":"590-602","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":41,"special_numbering":"C","title":["The use of prophylaxis in the treatment of rare bleeding disorders"],"prefix":"10.1016","volume":"196","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2821-7159","authenticated-orcid":false,"given":"Amy","family":"Shapiro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.thromres.2019.07.014_bb0005","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1111\/jth.13491","article-title":"Advances in the treatment of bleeding disorders","volume":"14","author":"Peyvandi","year":"2016","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.thromres.2019.07.014_bb0010","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1111\/j.1538-7836.2012.04844.x","article-title":"Classification of rare bleeding disorders (RBDs) based on the association between coagulant factor activity and clinical bleeding severity","volume":"10","author":"Peyvandi","year":"2012","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.thromres.2019.07.014_bb0015","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1111\/bjh.13058","article-title":"Guideline for the diagnosis and management of the rare coagulation disorders: a United Kingdom Haemophilia Centre Doctors\u2019 Organization guideline on behalf of the British Committee for Standards in Haematology","volume":"167","author":"Mumford","year":"2014","journal-title":"Br. J. Haematol."},{"issue":"Suppl. 2","key":"10.1016\/j.thromres.2019.07.014_bb0020","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1016\/S0049-3848(13)70004-5","article-title":"Epidemiology and treatment of congenital fibrinogen deficiency","volume":"130","author":"Peyvandi","year":"2012","journal-title":"Thromb. Res."},{"key":"10.1016\/j.thromres.2019.07.014_bb0025","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1055\/s-0033-1349221","article-title":"Rare bleeding disorders: worldwide efforts for classification, diagnosis, and management","volume":"39","author":"Peyvandi","year":"2013","journal-title":"Semin. Thromb. Hemost."},{"key":"10.1016\/j.thromres.2019.07.014_bb0030","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1111\/j.1538-7836.2012.04653.x","article-title":"Coagulation factor activity and clinical bleeding severity in rare bleeding disorders: results from the European Network of Rare Bleeding Disorders","volume":"10","author":"Peyvandi","year":"2012","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.thromres.2019.07.014_bb0035","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1182\/asheducation-2016.1.663","article-title":"Treatment of rare factor deficiencies in 2016","volume":"2016","author":"Peyvandi","year":"2016","journal-title":"Hematology Am Soc Hematol Educ Program."},{"issue":"Suppl. 1","key":"10.1016\/j.thromres.2019.07.014_bb0040","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1111\/j.1538-7836.2011.04372.x","article-title":"Gynecological and obstetrical manifestations of inherited bleeding disorders in women","volume":"9","author":"Peyvandi","year":"2011","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.thromres.2019.07.014_bb0045","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1046\/j.1365-2141.1999.01681.x","article-title":"Bleeding and thrombosis in 55 patients with inherited afibrinogenaemia","volume":"107","author":"Lak","year":"1999","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.thromres.2019.07.014_bb0050","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1111\/j.1537-2995.2010.02612.x","article-title":"Is primary prophylaxis required in afibrinogenemia?","volume":"50","author":"Polack","year":"2010","journal-title":"Transfusion."},{"key":"10.1016\/j.thromres.2019.07.014_bb0055","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1046\/j.1365-2516.2000.00448.x","article-title":"Spontaneous intracranial bleeding in two patients with congenital afibrinogenaemia and the role of replacement therapy","volume":"6","author":"Parameswaran","year":"2000","journal-title":"Haemophilia."},{"key":"10.1016\/j.thromres.2019.07.014_bb0060","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1111\/vox.12424","article-title":"Post-authorization safety study of Clottafact((R)), a triply secured fibrinogen concentrate in congenital afibrinogenemia. A prospective observational study","volume":"111","author":"Negrier","year":"2016","journal-title":"Vox Sang."},{"key":"10.1016\/j.thromres.2019.07.014_bb0065","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1111\/j.1538-7836.2011.04424.x","article-title":"Fibrinogen replacement therapy for congenital fibrinogen deficiency","volume":"9","author":"Bornikova","year":"2011","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.thromres.2019.07.014_bb0070","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1111\/hae.12507","article-title":"Thrombosis of abdominal aorta in congenital afibrinogenemia: case report and review of literature","volume":"21","author":"Sartori","year":"2015","journal-title":"Haemophilia."},{"key":"10.1016\/j.thromres.2019.07.014_bb0075","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1055\/s-0036-1581103","article-title":"Severe thrombotic complications in congenital Afibrinogenemia: a pathophysiological and management dilemma","volume":"42","author":"Santoro","year":"2016","journal-title":"Semin. Thromb. Hemost."},{"key":"10.1016\/j.thromres.2019.07.014_bb0080","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1002\/(SICI)1096-8652(199607)52:3<237::AID-AJH24>3.0.CO;2-B","article-title":"Congenital afibrinogenemia: treatment of excessive menstrual bleeding with continuous oral contraceptive","volume":"52","author":"Rizk","year":"1996","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.thromres.2019.07.014_bb0085","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1111\/j.1365-2516.2009.01984.x","article-title":"Pregnancy and rare bleeding disorders","volume":"15","author":"Kadir","year":"2009","journal-title":"Haemophilia."},{"key":"10.1016\/j.thromres.2019.07.014_bb0090","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1111\/j.1365-2141.1991.tb04491.x","article-title":"Pregnancy in congenital afibrinogenaemia: report of a successful case and review of the literature","volume":"78","author":"Grech","year":"1991","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.thromres.2019.07.014_bb0095","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1046\/j.1365-2141.2000.01993.x","article-title":"Prenatal and peripartum management of congenital afibrinogenaemia","volume":"109","author":"Kobayashi","year":"2000","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.thromres.2019.07.014_bb0100","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1055\/s-0033-1349222","article-title":"Congenital fibrinogen disorders: an update","volume":"39","author":"de Moerloose","year":"2013","journal-title":"Semin. Thromb. Hemost."},{"key":"10.1016\/j.thromres.2019.07.014_bb0105","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1111\/j.1538-7836.2006.02014.x","article-title":"Incidence of bleeding symptoms in 100 patients with inherited afibrinogenemia or hypofibrinogenemia","volume":"4","author":"Peyvandi","year":"2006","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.thromres.2019.07.014_bb0110","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1002\/pbc.24387","article-title":"Prophylactic administration of prothrombin complex concentrates for congenital prothrombin deficiency with a novel frameshift mutation, prothrombin saitama","volume":"60","author":"Seki","year":"2013","journal-title":"Pediatr. Blood Cancer"},{"key":"10.1016\/j.thromres.2019.07.014_bb0115","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1111\/j.1365-2516.2009.02118.x","article-title":"A review of long-term prophylaxis in the rare inherited coagulation factor deficiencies","volume":"16","author":"Todd","year":"2010","journal-title":"Haemophilia"},{"key":"10.1016\/j.thromres.2019.07.014_bb0120","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1111\/j.1365-2141.2010.08352.x","article-title":"Prophylaxis in severe prothrombin deficiency","volume":"152","author":"Mathias","year":"2011","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.thromres.2019.07.014_bb0125","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1055\/s-2007-973512","article-title":"Hereditary prothrombin deficiency presenting as intracranial haematoma in infancy","volume":"30","author":"Strijks","year":"1999","journal-title":"Neuropediatrics."},{"key":"10.1016\/j.thromres.2019.07.014_bb0130","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1111\/j.1538-7836.2003.t01-1-00553.x","article-title":"North American Rare Bleeding Disorder Study G. Rare Bleeding Disorder Registry: deficiencies of factors II, V, VII, X, XIII, fibrinogen and dysfibrinogenemias","volume":"2","author":"Acharya","year":"2004","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.thromres.2019.07.014_bb0135","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1055\/s-0037-1614361","article-title":"Rare coagulation disorders","volume":"82","author":"Peyvandi","year":"1999","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.thromres.2019.07.014_bb0140","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1182\/blood-2014-08-532820","article-title":"Rare bleeding disorders: diagnosis and treatment","volume":"125","author":"Palla","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2019.07.014_bb0145","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1055\/s-2007-994113","article-title":"Pregnancies in a patient with congenital absence of prothrombin activity: case report","volume":"14","author":"Catanzarite","year":"1997","journal-title":"Am. J. Perinatol."},{"key":"10.1016\/j.thromres.2019.07.014_bb0150","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1097\/01.mph.0000130220.33907.5a","article-title":"Successful prophylactic treatment for bleeding in a girl with severe hereditary prothrombin deficiency using a prothrombin complex concentrate (Bebulin VH)","volume":"26","author":"Lobel","year":"2004","journal-title":"J. Pediatr. Hematol. Oncol."},{"key":"10.1016\/j.thromres.2019.07.014_bb0155","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1159\/000089467","article-title":"Pregnancy and oral contraceptives in congenital bleeding disorders of the vitamin K-dependent coagulation factors","volume":"115","author":"Girolami","year":"2006","journal-title":"Acta Haematol."},{"key":"10.1016\/j.thromres.2019.07.014_bb0160","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1055\/s-0033-1348948","article-title":"Congenital prothrombin deficiency: an update","volume":"39","author":"Lancellotti","year":"2013","journal-title":"Semin. Thromb. Hemost."},{"key":"10.1016\/j.thromres.2019.07.014_bb0165","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1097\/00001721-199810000-00001","article-title":"Congenital deficiencies and abnormalities of prothrombin","volume":"9","author":"Girolami","year":"1998","journal-title":"Blood Coagul. Fibrinolysis"},{"key":"10.1016\/j.thromres.2019.07.014_bb0170","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1182\/blood.V56.5.835.835","article-title":"Successful management of bleeding in a patient with factor V inhibitor by platelet transfusions","volume":"56","author":"Chediak","year":"1980","journal-title":"Blood."},{"key":"10.1016\/j.thromres.2019.07.014_bb0175","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1055\/s-0029-1225760","article-title":"Factor V deficiency","volume":"35","author":"Asselta","year":"2009","journal-title":"Semin. Thromb. Hemost."},{"key":"10.1016\/j.thromres.2019.07.014_bb0180","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1007\/s11095-016-1895-3","article-title":"Safety, stability and pharmacokinetic properties of (super)factor Va, a novel engineered coagulation factor V for treatment of severe bleeding","volume":"33","author":"Gale","year":"2016","journal-title":"Pharm. Res."},{"key":"10.1016\/j.thromres.2019.07.014_bb0185","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1046\/j.1365-2516.2000.00362.x","article-title":"Severe factor V deficiency and neonatal intracranial haemorrhage: a case report","volume":"6","author":"Salooja","year":"2000","journal-title":"Haemophilia."},{"key":"10.1016\/j.thromres.2019.07.014_bb0190","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1136\/adc.59.10.997","article-title":"Factor V deficiency and antenatal intraventricular haemorrhage","volume":"59","author":"Whitelaw","year":"1984","journal-title":"Arch. Dis. Child."},{"key":"10.1016\/j.thromres.2019.07.014_bb0195","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1111\/hae.12053","article-title":"Management of surgical procedures in children with severe FV deficiency: experience of 13 surgeries","volume":"19","author":"Mathias","year":"2013","journal-title":"Haemophilia."},{"key":"10.1016\/j.thromres.2019.07.014_bb0200","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1111\/j.1365-2516.2005.01056.x","article-title":"Pregnancy and oral contraceptives in factor V deficiency: a study of 22 patients (five homozygotes and 17 heterozygotes) and review of the literature","volume":"11","author":"Girolami","year":"2005","journal-title":"Haemophilia."},{"key":"10.1016\/j.thromres.2019.07.014_bb0205","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1046\/j.1365-2141.1998.01077.x","article-title":"Symptoms of inherited factor V deficiency in 35 Iranian patients","volume":"103","author":"Lak","year":"1998","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.thromres.2019.07.014_bb0210","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1111\/j.1365-2516.2008.01894.x","article-title":"Menorrhagia and reproductive health in rare bleeding disorders: a study from the Indian subcontinent","volume":"15","author":"Vijapurkar","year":"2009","journal-title":"Haemophilia."},{"key":"10.1016\/j.thromres.2019.07.014_bb0215","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1007\/s12185-016-1981-7","article-title":"Miscarriage and recurrent miscarriage in patients with congenital factor V deficiency: a report of six cases in Iran","volume":"103","author":"Naderi","year":"2016","journal-title":"Int. J. Hematol."},{"key":"10.1016\/j.thromres.2019.07.014_bb0220","doi-asserted-by":"crossref","first-page":"e318","DOI":"10.1111\/hae.12210","article-title":"Successful delivery in patients with severe congenital factor V deficiency: a study of five homozygous patients","volume":"19","author":"Younesi","year":"2013","journal-title":"Haemophilia."},{"key":"10.1016\/j.thromres.2019.07.014_bb0225","doi-asserted-by":"crossref","first-page":"299","DOI":"10.12891\/ceog3351.2017","article-title":"Pregnancies with factor V deficiency: a case report and review of the literature","volume":"44","author":"Maeda","year":"2017","journal-title":"Clin Exp Obstet Gynecol."},{"key":"10.1016\/j.thromres.2019.07.014_bb0230","doi-asserted-by":"crossref","first-page":"384","DOI":"10.12891\/ceog1867.2015","article-title":"The use of fresh frozen plasma for reproduction in severe factor V deficiency","volume":"42","author":"Rouzi","year":"2015","journal-title":"Clin Exp Obstet Gynecol."},{"key":"10.1016\/j.thromres.2019.07.014_bb0235","doi-asserted-by":"crossref","unstructured":"Iwase A, Goto M, Manabe S, Hirokawa W, Kobayashi H, Nakahara T, et al. Successful fertility management of a patient with factor V deficiency: planned transfusion of fresh frozen plasma under infertility treatment. Fertil Steril. 2011;95:2124 e5\u20137.","DOI":"10.1016\/j.fertnstert.2011.01.011"},{"key":"10.1016\/j.thromres.2019.07.014_bb0240","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1111\/j.1365-2516.2004.00944.x","article-title":"The rare coagulation disorders\u2013review with guidelines for management from the United Kingdom Haemophilia Centre Doctors\u2019 organisation","volume":"10","author":"Bolton-Maggs","year":"2004","journal-title":"Haemophilia."},{"key":"10.1016\/j.thromres.2019.07.014_bb0245","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1111\/j.1365-2516.2005.00956.x","article-title":"The use of activated recombinant coagulation factor VII during haemarthroses and synovectomy in a patient with congenital severe factor V deficiency","volume":"11","author":"Gonz\u00e1lez-Boullosa","year":"2005","journal-title":"Haemophilia."},{"key":"10.1016\/j.thromres.2019.07.014_bb0250","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1111\/j.1365-2516.2008.01785.x","article-title":"Factor V deficiency: a concise review","volume":"14","author":"Huang","year":"2008","journal-title":"Haemophilia."},{"key":"10.1016\/j.thromres.2019.07.014_bb0255","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1111\/jth.13207","article-title":"Desmopressin acetate as a haemostatic elevator in individuals with combined deficiency of factors V and VIII: a clinical trial","volume":"14","author":"Mansouritorghabeh","year":"2016","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.thromres.2019.07.014_bb0260","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1046\/j.1365-2141.1998.00620.x","article-title":"Bleeding symptoms in 27 Iranian patients with the combined deficiency of factor V and factor VIII","volume":"100","author":"Peyvandi","year":"1998","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.thromres.2019.07.014_bb0265","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1111\/j.1365-2516.2008.01845.x","article-title":"Combined FV and FVIII deficiency","volume":"14","author":"Spreafico","year":"2008","journal-title":"Haemophilia."},{"key":"10.1016\/j.thromres.2019.07.014_bb0270","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1056\/NEJM198211043071907","article-title":"Combined factor V and factor VIII deficiency among non-Ashkenazi Jews","volume":"307","author":"Seligsohn","year":"1982","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.thromres.2019.07.014_bb0275","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1111\/j.1365-2516.2004.00890.x","article-title":"Haemorrhagic symptoms in patients with combined factors V and VIII deficiency in north-eastern Iran","volume":"10","author":"Mansouritorgabeh","year":"2004","journal-title":"Haemophilia"},{"key":"10.1016\/j.thromres.2019.07.014_bb0280","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1002\/ajh.21741","article-title":"Clinical manifestations of combined factor V and VIII deficiency: a series of 37 cases from a single center in India","volume":"85","author":"Viswabandya","year":"2010","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.thromres.2019.07.014_bb0285","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1097\/MBC.0000000000000407","article-title":"Congenital factor V and VIII deficiency in women: a systematic review of literature and report of two new cases","volume":"27","author":"Spiliopoulos","year":"2016","journal-title":"Blood Coagul. Fibrinolysis"},{"key":"10.1016\/j.thromres.2019.07.014_bb0290","first-page":"343717","article-title":"Successful pregnancy in a patient with combined deficiency of factor V and factor VIII","volume":"2014","author":"El Adib","year":"2014","journal-title":"Case Rep. Obstet. Gynecol."},{"key":"10.1016\/j.thromres.2019.07.014_bb0295","doi-asserted-by":"crossref","first-page":"e43","DOI":"10.1016\/j.annfar.2014.01.005","article-title":"Factor V and VIII combined deficiency: clinical perioperative management for tonsillectomy in a child","volume":"33","author":"Lanchon","year":"2014","journal-title":"Ann. Fr. Anesth. Reanim."},{"key":"10.1016\/j.thromres.2019.07.014_bb0300","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1002\/jca.21478","article-title":"Factor V and VIII deficiency treated with therapeutic plasma exchange prior to redo mitral valve replacement","volume":"32","author":"Brown","year":"2017","journal-title":"J. Clin. Apher."},{"key":"10.1016\/j.thromres.2019.07.014_bb0305","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1111\/hae.12128","article-title":"Successful percutaneous coronary intervention in a patient with combined deficiency of FV and FVIII due to novel compound heterozygous mutations in LMAN1","volume":"19","author":"Patel","year":"2013","journal-title":"Haemophilia."},{"key":"10.1016\/j.thromres.2019.07.014_bb0310","doi-asserted-by":"crossref","first-page":"e492","DOI":"10.1111\/hae.12756","article-title":"Successful abdominal operation without replacement therapy in a patient with combined factor V (FV) and FVIII deficiency due to novel homozygous mutation in LMAN1","volume":"21","author":"Wang","year":"2015","journal-title":"Haemophilia."},{"key":"10.1016\/j.thromres.2019.07.014_bb0315","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1177\/1076029616670257","article-title":"Factor VII deficiency: from basics to clinical laboratory diagnosis and patient management","volume":"23","author":"Sevenet","year":"2017","journal-title":"Clin. Appl. Thromb. Hemost."},{"key":"10.1016\/j.thromres.2019.07.014_bb0320","doi-asserted-by":"crossref","first-page":"538","DOI":"10.3324\/haematol.2012.074039","article-title":"Prophylaxis in congenital factor VII deficiency: indications, efficacy and safety. Results from the Seven Treatment Evaluation Registry (STER)","volume":"98","author":"Napolitano","year":"2013","journal-title":"Haematologica."},{"key":"10.1016\/j.thromres.2019.07.014_bb0325","doi-asserted-by":"crossref","first-page":"2362","DOI":"10.1111\/jth.14296","article-title":"The future of bypassing agents for hemophilia with inhibitors in the era of novel agents","volume":"16","author":"Shapiro","year":"2018","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.thromres.2019.07.014_bb0330","first-page":"1170","article-title":"International registry on congenital factor VII deficiency","volume":"14","author":"Lapecorella","year":"2008","journal-title":"Factor VII Deficiency: Defining the Clinical Picture and Optimizing Therapeutic Options. Haemophilia."},{"key":"10.1016\/j.thromres.2019.07.014_bb0335","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1002\/ajh.2830500408","article-title":"Prophylaxis and therapy with factor VII concentrate (human) immuno, vapor heated in patients with congenital factor VII deficiency: a summary of case reports","volume":"50","author":"Cohen","year":"1995","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.thromres.2019.07.014_bb0340","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1111\/hae.12702","article-title":"Long-term prophylaxis in severe factor VII deficiency","volume":"21","author":"Siboni","year":"2015","journal-title":"Haemophilia"},{"key":"10.1016\/j.thromres.2019.07.014_bb0345","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.bcmd.2016.12.008","article-title":"Primary prophylaxis for children with severe congenital factor VII deficiency - clinical and laboratory assessment","volume":"67","author":"Kuperman","year":"2017","journal-title":"Blood Cells Mol. Dis."},{"key":"10.1016\/j.thromres.2019.07.014_bb1000","doi-asserted-by":"crossref","first-page":"e188","DOI":"10.1111\/hae.12376","article-title":"Inhibitors to factor VII in congenital factor VII deficiency","volume":"20","author":"Batorova","year":"2014","journal-title":"Haemophilia."},{"key":"10.1016\/j.thromres.2019.07.014_bb1005","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1111\/hae.12978","article-title":"Women with congenital factor VII deficiency: clinical phenotype and treatment options from two international studies","volume":"22","author":"Napolitano","year":"2016","journal-title":"Haemophilia."},{"key":"10.1016\/j.thromres.2019.07.014_bb1010","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1111\/j.1365-2516.2006.01287.x","article-title":"Pregnancy in women with congenital factor VII deficiency","volume":"12","author":"Kulkarni","year":"2006","journal-title":"Haemophilia."},{"key":"10.1016\/j.thromres.2019.07.014_bb1015","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1160\/TH09-10-0704","article-title":"Haemostatic reference intervals in pregnancy","volume":"103","author":"Szecsi","year":"2010","journal-title":"Thromb. Haemost."},{"issue":"Suppl. 3","key":"10.1016\/j.thromres.2019.07.014_bb1020","doi-asserted-by":"crossref","first-page":"S116","DOI":"10.1016\/S0049-3848(11)70031-7","article-title":"Post-partum hemorrhage in women with rare bleeding disorders","volume":"127","author":"Peyvandi","year":"2011","journal-title":"Thromb. Res."},{"key":"10.1016\/j.thromres.2019.07.014_bb1025","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1111\/hae.12167","article-title":"Is prophylaxis required for delivery in women with factor VII deficiency?","volume":"19","author":"Baumann Kreuziger","year":"2013","journal-title":"Haemophilia."},{"key":"10.1016\/j.thromres.2019.07.014_bb1030","first-page":"704","article-title":"Analysis of biological phenotypes from 42 patients with inherited factor VII deficiency: can biological tests predict the bleeding risk?","volume":"89","author":"Giansily-Blaizot","year":"2004","journal-title":"Haematologica."},{"key":"10.1016\/j.thromres.2019.07.014_bb0385","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1097\/MBC.0000000000000258","article-title":"Prevention of bleeding and hemorrhagic complications in surgical patients with inherited factor VII deficiency","volume":"26","author":"Wiszniewski","year":"2015","journal-title":"Blood Coagul. Fibrinolysis"},{"key":"10.1016\/j.thromres.2019.07.014_bb0390","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1111\/j.1365-2141.2010.08287.x","article-title":"Recombinant, activated factor VII for surgery in factor VII deficiency: a prospective evaluation - the surgical STER","volume":"152","author":"Mariani","year":"2011","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.thromres.2019.07.014_bb0395","doi-asserted-by":"crossref","first-page":"331","DOI":"10.21037\/atm.2018.08.34","article-title":"Rare congenital bleeding disorders","volume":"6","author":"Franchini","year":"2018","journal-title":"Ann Transl Med."},{"key":"10.1016\/j.thromres.2019.07.014_bb0400","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1080\/17425255.2016.1237504","article-title":"Plasma-derived human factor X concentrate for on-demand and perioperative treatment in factor X-deficient patients: pharmacology, pharmacokinetics, efficacy, and safety","volume":"13","author":"Shapiro","year":"2017","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"10.1016\/j.thromres.2019.07.014_bb0405","doi-asserted-by":"crossref","unstructured":"Liesner R, Akanezi C, Norton M, Payne J. Prophylactic treatment of bleeding episodes in children <12 years with moderate to severe hereditary factor X deficiency (FXD): Efficacy and safety of a high-purity plasma-derived factor X (pdFX) concentrate. Haemophilia. 2018:epub ahead of print.","DOI":"10.1111\/hae.13500"},{"key":"10.1016\/j.thromres.2019.07.014_bb0410","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1111\/hae.12893","article-title":"Efficacy, safety and pharmacokinetics of a new high-purity factor X concentrate in subjects with hereditary factor X deficiency","volume":"22","author":"Austin","year":"2016","journal-title":"Haemophilia."},{"key":"10.1016\/j.thromres.2019.07.014_bb0415","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1111\/hae.12954","article-title":"Experience of a new high-purity factor X concentrate in subjects with hereditary factor X deficiency undergoing surgery","volume":"22","author":"Escobar","year":"2016","journal-title":"Haemophilia."},{"key":"10.1016\/j.thromres.2019.07.014_bb0420","unstructured":"Bio Products Laboratory Ltd. Coagadex [package insert]. 2008. Access date. Available from: https:\/\/www.fda.gov\/downloads\/ApprovedProducts\/UCM468127.pdf."},{"key":"10.1016\/j.thromres.2019.07.014_bb0425","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1111\/j.1365-2516.2011.02635.x","article-title":"Efficacy of prophylaxis and genotype-phenotype correlation in patients with severe Factor X deficiency in Iran","volume":"18","author":"Karimi","year":"2012","journal-title":"Haemophilia."},{"issue":"Suppl. 1","key":"10.1016\/j.thromres.2019.07.014_bb0430","doi-asserted-by":"crossref","first-page":"S29","DOI":"10.1016\/j.thromres.2006.01.015","article-title":"Prophylaxis in rare coagulation disorders \u2014 factor X deficiency","volume":"118","author":"Auerswald","year":"2006","journal-title":"Thromb. Res."},{"key":"10.1016\/j.thromres.2019.07.014_bb0435","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1046\/j.1365-2516.2001.00485.x","article-title":"Prophylactic treatment of severe factor X deficiency with prothrombin complex concentrate","volume":"7","author":"Kouides","year":"2001","journal-title":"Haemophilia."},{"key":"10.1016\/j.thromres.2019.07.014_bb0440","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1046\/j.1365-2141.2002.03932.x","article-title":"The role of primary prophylactic factor replacement therapy in children with severe factor X deficiency","volume":"119","author":"McMahon","year":"2002","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.thromres.2019.07.014_bb0445","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1111\/j.1365-2516.2006.01303.x","article-title":"Factor X deficiency: clinical manifestation of 102 subjects from Europe and Latin America with mutations in the factor 10 gene","volume":"12","author":"Herrmann","year":"2006","journal-title":"Haemophilia."},{"key":"10.1016\/j.thromres.2019.07.014_bb0450","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1046\/j.1365-2141.1998.00806.x","article-title":"Congenital factor X deficiency: spectrum of bleeding symptoms in 32 Iranian patients","volume":"102","author":"Peyvandi","year":"1998","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.thromres.2019.07.014_bb0455","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1111\/jth.13983","article-title":"Efficacy, safety and pharmacokinetics of a new high-purity factor X concentrate in women and girls with hereditary factor X deficiency","volume":"16","author":"Kulkarni","year":"2018","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.thromres.2019.07.014_bb0460","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1055\/s-0029-1225763","article-title":"Factor X deficiency","volume":"35","author":"Menegatti","year":"2009","journal-title":"Semin. Thromb. Hemost."},{"key":"10.1016\/j.thromres.2019.07.014_bb0465","doi-asserted-by":"crossref","first-page":"e277","DOI":"10.1111\/j.1365-2516.2011.02724.x","article-title":"Factor X deficiency and pregnancy: preconception counselling and therapeutic options","volume":"18","author":"Nance","year":"2012","journal-title":"Haemophilia."},{"key":"10.1016\/j.thromres.2019.07.014_bb0470","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1046\/j.1537-2995.1985.25185116511.x","article-title":"Replacement therapy for congenital factor X deficiency","volume":"25","author":"Knight","year":"1985","journal-title":"Transfusion."},{"key":"10.1016\/j.thromres.2019.07.014_bb0475","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1620\/tjem.133.1","article-title":"Congenital factor X deficiency in Japan","volume":"133","author":"Mori","year":"1981","journal-title":"Tohoku J. Exp. Med."},{"key":"10.1016\/j.thromres.2019.07.014_bb0480","doi-asserted-by":"crossref","first-page":"e369","DOI":"10.1111\/hae.12262","article-title":"Femur fracture in a woman with severe factor X deficiency - an experience using factor X concentrate in surgery","volume":"19","author":"Martin-Salces","year":"2013","journal-title":"Haemophilia."},{"key":"10.1016\/j.thromres.2019.07.014_bb0485","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1111\/hae.12678","article-title":"Factor XI-related thrombosis and the role of concentrate treatment in factor XI deficiency","volume":"21","author":"Pike","year":"2015","journal-title":"Haemophilia."},{"key":"10.1016\/j.thromres.2019.07.014_bb0490","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1053\/j.seminhematol.2005.11.018","article-title":"Inhibitors to factor XI in patients with severe factor XI deficiency","volume":"43","author":"Salomon","year":"2006","journal-title":"Semin. Hematol."},{"key":"10.1016\/j.thromres.2019.07.014_bb0495","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1111\/hae.12628","article-title":"Bleeding phenotype and correlation with factor XI (FXI) activity in congenital FXI deficiency: results of a retrospective study from a single centre","volume":"21","author":"Santoro","year":"2015","journal-title":"Haemophilia."},{"issue":"Suppl. 1","key":"10.1016\/j.thromres.2019.07.014_bb0500","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1111\/j.1538-7836.2009.03395.x","article-title":"Factor XI deficiency in humans","volume":"7","author":"Seligsohn","year":"2009","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.thromres.2019.07.014_bb0505","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1111\/hae.12856","article-title":"Gynaecological and obstetrical bleeding in women with factor XI deficiency - a systematic review","volume":"22","author":"Wiewel-Verschueren","year":"2016","journal-title":"Haemophilia."},{"key":"10.1016\/j.thromres.2019.07.014_bb0510","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1097\/00001721-200501000-00006","article-title":"Plasma replacement therapy during labor is not mandatory for women with severe factor XI deficiency","volume":"16","author":"Salomon","year":"2005","journal-title":"Blood Coagul. Fibrinolysis"},{"key":"10.1016\/j.thromres.2019.07.014_bb0515","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1111\/j.1471-0528.2007.01296.x","article-title":"Pregnancy outcome in factor XI deficiency: incidence of miscarriage, antenatal and postnatal haemorrhage in 33 women with Factor XI deficiency","volume":"114","author":"Myers","year":"2007","journal-title":"BJOG."},{"key":"10.1016\/j.thromres.2019.07.014_bb0520","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.ejogrb.2017.06.008","article-title":"Management of parturients with Factor XI deficiency-10year case series and review of literature","volume":"215","author":"Verghese","year":"2017","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"10.1016\/j.thromres.2019.07.014_bb0525","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1111\/hae.12682","article-title":"Ongoing risk of thrombosis with factor XI concentrate: 5\u202fyears experience in two centres","volume":"21","author":"Batty","year":"2015","journal-title":"Haemophilia."},{"key":"10.1016\/j.thromres.2019.07.014_bb0530","doi-asserted-by":"crossref","DOI":"10.1111\/hae.12457","article-title":"FXI concentrate use and risk of thrombosis","volume":"20","author":"Bolton-Maggs","year":"2014","journal-title":"Haemophilia."},{"key":"10.1016\/j.thromres.2019.07.014_bb0535","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1111\/j.1365-2516.2008.01695.x","volume":"14","author":"Keeling","year":"2008","journal-title":"Haemophilia."},{"key":"10.1016\/j.thromres.2019.07.014_bb0540","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1111\/j.1365-2516.2006.01304.x","article-title":"Variable bleeding manifestations characterize different types of surgery in patients with severe factor XI deficiency enabling parsimonious use of replacement therapy","volume":"12","author":"Salomon","year":"2006","journal-title":"Haemophilia."},{"key":"10.1016\/j.thromres.2019.07.014_bb0545","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1160\/TH10-12-0816","article-title":"Monitoring low dose recombinant factor VIIa therapy in patients with severe factor XI deficiency undergoing surgery","volume":"106","author":"Riddell","year":"2011","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.thromres.2019.07.014_bb0550","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1111\/j.1365-2516.2009.02043.x","article-title":"Lower doses of rFVIIa therapy are safe and effective for surgical interventions in patients with severe FXI deficiency and inhibitors","volume":"15","author":"Kenet","year":"2009","journal-title":"Haemophilia."},{"key":"10.1016\/j.thromres.2019.07.014_bb0555","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1160\/TH09-03-0172","article-title":"Recombinant activated factor VII and tranexamic acid are haemostatically effective during major surgery in factor XI-deficient patients with inhibitor antibodies","volume":"102","author":"Livnat","year":"2009","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.thromres.2019.07.014_bb0560","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1111\/j.1365-2516.2008.01663.x","article-title":"Recombinant factor VIIa to prevent surgical bleeding in factor XI deficiency","volume":"14","author":"O\u2019Connell","year":"2008","journal-title":"Haemophilia"},{"key":"10.1016\/j.thromres.2019.07.014_bb0565","unstructured":"Novo Nordisk. Tretten, coagulation factor XIII A-subunit (recombinant) [Package insert]. 2016. Access date: November 15, 2018. Available from: https:\/\/www.novo-pi.com\/tretten.pdf."},{"key":"10.1016\/j.thromres.2019.07.014_bb0570","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1111\/j.1365-2516.2008.01857.x","article-title":"Factor XIII deficiency","volume":"14","author":"Hsieh","year":"2008","journal-title":"Haemophilia."},{"key":"10.1016\/j.thromres.2019.07.014_bb0575","doi-asserted-by":"crossref","first-page":"5111","DOI":"10.1182\/blood-2011-10-386045","article-title":"Recombinant factor XIII: a safe and novel treatment for congenital factor XIII deficiency","volume":"119","author":"Inbal","year":"2012","journal-title":"Blood."},{"key":"10.1016\/j.thromres.2019.07.014_bb0580","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1097\/MBC.0000000000000578","article-title":"Long-term prophylaxis in patients with severe congenital factor XIII deficiency is not complicated by inhibitor formation","volume":"28","author":"Naderi","year":"2017","journal-title":"Blood Coagul. Fibrinolysis"},{"key":"10.1016\/j.thromres.2019.07.014_bb0585","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1097\/MBC.0000000000000029","article-title":"Factor XIII deficiency management: a review of the literature","volume":"25","author":"Odame","year":"2014","journal-title":"Blood Coagul. Fibrinolysis"},{"key":"10.1016\/j.thromres.2019.07.014_bb0590","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1111\/j.1538-7836.2011.04281.x","article-title":"Successful long-term replacement therapy with FXIII concentrate (Fibrogammin((R)) P) for severe congenital factor XIII deficiency: a prospective multicentre study","volume":"9","author":"Dreyfus","year":"2011","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.thromres.2019.07.014_bb0595","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1111\/hae.12524","article-title":"Efficacy and safety of prophylactic treatment with plasma-derived factor XIII concentrate (human) in patients with congenital factor XIII deficiency","volume":"21","author":"Ashley","year":"2015","journal-title":"Haemophilia."},{"key":"10.1016\/j.thromres.2019.07.014_bb0600","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1046\/j.1538-7836.2003.00338.x","article-title":"Pattern of symptoms in 93 Iranian patients with severe factor XIII deficiency","volume":"1","author":"Lak","year":"2003","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.thromres.2019.07.014_bb0605","doi-asserted-by":"crossref","first-page":"e349","DOI":"10.1111\/hae.12259","article-title":"Congenital factor XIII deficiency in women: a systematic review of literature","volume":"19","author":"Sharief","year":"2013","journal-title":"Haemophilia."},{"key":"10.1016\/j.thromres.2019.07.014_bb0610","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1097\/00006254-200002000-00024","article-title":"Bleeding risk and reproductive capacity among patients with factor XIII deficiency: a case presentation and review of the literature","volume":"55","author":"Burrows","year":"2000","journal-title":"Obstet Gynecol Surv."},{"key":"10.1016\/j.thromres.2019.07.014_bb0615","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.siny.2011.07.006","article-title":"Management of pregnancy and delivery in women with inherited bleeding disorders","volume":"16","author":"Peyvandi","year":"2011","journal-title":"Semin. Fetal Neonatal Med."},{"key":"10.1016\/j.thromres.2019.07.014_bb0620","doi-asserted-by":"crossref","first-page":"2300","DOI":"10.1111\/jth.13872","article-title":"A large case series on surgical outcomes in congenital factor XIII deficiency patients in Iran","volume":"15","author":"Naderi","year":"2017","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.thromres.2019.07.014_bb0625","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1055\/s-0038-1624581","article-title":"Recombinant FXIII (rFXIII-A2) prophylaxis prevents bleeding and allows for surgery in patients with congenital FXIII A-subunit deficiency","volume":"118","author":"Carcao","year":"2018","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.thromres.2019.07.014_bb0630","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1001\/archinte.1989.00390080049012","article-title":"Plasma a2-antiplasmin activity: role in the evaluation and management of fibrinolytic states and other bleeding disorders","volume":"149","author":"Williams","year":"1989","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.thromres.2019.07.014_bb0635","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1111\/jth.14160","article-title":"Hemorrhagic disorders of fibrinolysis: a clinical review","volume":"16","author":"Saes","year":"2018","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.thromres.2019.07.014_bb0640","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1111\/j.1365-2516.2008.01766.x","article-title":"Alpha2-antiplasmin and its deficiency: fibrinolysis out of balance","volume":"14","author":"Carpenter","year":"2008","journal-title":"Haemophilia."},{"key":"10.1016\/j.thromres.2019.07.014_bb0645","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1182\/blood.V90.1.204.204_204_208","article-title":"Human plasminogen activator inhibitor-1 (PAI-1) deficiency: characterization of a large kindred with a null mutation in the PAI-1 gene","volume":"90","author":"Fay","year":"1997","journal-title":"Blood."},{"key":"10.1016\/j.thromres.2019.07.014_bb0650","doi-asserted-by":"crossref","first-page":"698648","DOI":"10.1155\/2011\/698648","article-title":"Alpha II antiplasmin deficiency complicating pregnancy: a case report","volume":"2011","author":"Dawley","year":"2011","journal-title":"Obstet. Gynecol. Int."},{"key":"10.1016\/j.thromres.2019.07.014_bb0655","first-page":"321","article-title":"Intramedullary multiple hematomas in siblings with congenital alpha-2-plasmin inhibitor deficiency: orthopedic surgery with protection by tranexamic acid","volume":"21","author":"Takahashi","year":"1991","journal-title":"Haemostasis."},{"key":"10.1016\/j.thromres.2019.07.014_bb0660","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1111\/j.1365-2516.2004.00914.x","article-title":"Haemostatic management of intraoral bleeding in patients with congenital deficiency of alpha2-plasmin inhibitor or plasminogen activator inhibitor-1","volume":"10","author":"Morimoto","year":"2004","journal-title":"Haemophilia."},{"key":"10.1016\/j.thromres.2019.07.014_bb0665","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1111\/j.1365-2516.2008.01834.x","article-title":"Plasminogen activator inhibitor type 1 deficiency","volume":"14","author":"Mehta","year":"2008","journal-title":"Haemophilia."},{"key":"10.1016\/j.thromres.2019.07.014_bb0670","unstructured":"Heiman M, Gupta S, Khan SS, Vaughan DE, Shapiro AD. Complete plasminogen activator inhibitor 1 deficiency. 2017. Access date: August 28, 2017. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK447152\/."},{"key":"10.1016\/j.thromres.2019.07.014_bb0675","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1111\/j.1538-7836.2007.02585.x","article-title":"What is the clinical impact of low plasminogen activator inhibitor-1 (PAI-1) activity? A case report and study of the incidence of low PAI-1 antigen in a healthy population","volume":"5","author":"Santamaria","year":"2007","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.thromres.2019.07.014_bb0680","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1111\/hae.12313","article-title":"The obstetric, gynaecological and fertility implications of homozygous PAI-1 deficiency: single-centre experience","volume":"20","author":"Heiman","year":"2014","journal-title":"Haemophilia"},{"key":"10.1016\/j.thromres.2019.07.014_bb0685","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1177\/107602960401000316","article-title":"Menorrhagia due to a qualitative deficiency of plasminogen activator inhibitor-1: case report and literature review","volume":"10","author":"Repine","year":"2004","journal-title":"Clin. Appl. Thromb. Hemost."},{"key":"10.1016\/j.thromres.2019.07.014_bb0690","doi-asserted-by":"crossref","first-page":"e161","DOI":"10.1016\/j.thromres.2011.10.008","article-title":"The first report of uncontrollable subchorionic and retroplacental haemorrhage inducing preterm labour in complete PAI-1 deficiency in a human","volume":"129","author":"Iwaki","year":"2012","journal-title":"Thromb. Res."},{"key":"10.1016\/j.thromres.2019.07.014_bb0695","doi-asserted-by":"crossref","first-page":"e237","DOI":"10.1111\/hae.12929","article-title":"Total hip arthroplasty and total knee arthroplasty in a patient with congenital deficiency of plasminogen activator inhibitor-1","volume":"22","author":"Hirose","year":"2016","journal-title":"Haemophilia."},{"key":"10.1016\/j.thromres.2019.07.014_bb0700","doi-asserted-by":"crossref","first-page":"3650","DOI":"10.1182\/blood.V96.10.3650","article-title":"Novel mutation in the \u03b3-glutamyl carboxylase gene resulting in congenital combined deficiency of all vitamin K\u2013dependent blood coagulation factors","volume":"96","author":"Spronk","year":"2000","journal-title":"Blood."},{"key":"10.1016\/j.thromres.2019.07.014_bb0705","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1055\/s-0037-1614152","article-title":"Congenital deficiency of vitamin K dependent coagulation factors in two families presents as a genetic defect of the vitamin K-epoxide-reductase-complex","volume":"84","author":"Oldenburg","year":"2000","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.thromres.2019.07.014_bb0710","first-page":"808","article-title":"Combined deficiency of factors II, VII, IX, and X (Borgschulte-Grigsby deficiency) in pregnancy","volume":"97","author":"McMahon","year":"2001","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.thromres.2019.07.014_bb0715","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1055\/s-0037-1616072","article-title":"Congenital combined deficiencies of all vitamin K-dependent coagulation factors","volume":"86","author":"Mousallem","year":"2001","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.thromres.2019.07.014_bb0720","doi-asserted-by":"crossref","first-page":"4554","DOI":"10.1182\/blood.V92.12.4554","article-title":"A missense mutation in \u03b3-glutamyl carboxylase gene causes combined deficiency of all vitamin K-dependent blood coagulation factors","volume":"92","author":"Brenner","year":"1998","journal-title":"Blood."},{"key":"10.1016\/j.thromres.2019.07.014_bb0725","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1023\/A:1011237019082","article-title":"Anaphylactoid reactions to vitamin K","volume":"11","author":"Fiore","year":"2001","journal-title":"J. Thromb. Thrombolysis"},{"key":"10.1016\/j.thromres.2019.07.014_bb0730","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1182\/blood-2005-12-010660","article-title":"Compound heterozygosity of novel missense mutations in the gamma-glutamyl-carboxylase gene causes hereditary combined vitamin K-dependent coagulation factor deficiency","volume":"108","author":"Darghouth","year":"2006","journal-title":"Blood."},{"key":"10.1016\/j.thromres.2019.07.014_bb0735","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1177\/1076029608330473","article-title":"Effective hemostasis during minor surgery in a case of hereditary combined deficiency of vitamin K-dependent clotting factors","volume":"16","author":"Lapecorella","year":"2010","journal-title":"Clin. Appl. Thromb. Hemost."},{"key":"10.1016\/j.thromres.2019.07.014_bb0740","unstructured":"Di Paola J, Kunicki TJ, Nugent DJ. Rare Coagulation Disorders Resource Room - Congenital Platelet Function Disorders. Access date: November 21, 2018. Available from: http:\/\/www.rarecoagulationdisorders.org\/diseases\/congenital-platelet-function-disorders\/disease-overview"},{"key":"10.1016\/j.thromres.2019.07.014_bb0745","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1182\/blood.V75.7.1383.1383","article-title":"Glanzmann\u2019s thrombasthenia: the spectrum of clinical disease","volume":"75","author":"George","year":"1990","journal-title":"Blood."},{"key":"10.1016\/j.thromres.2019.07.014_bb0750","first-page":"73","article-title":"Platelet transfusion in a patient affected by Glanzmann\u2019s thrombasthenia with antibodies against GPIIb-IIIa","volume":"82","author":"Conte","year":"1997","journal-title":"Haematologica."},{"key":"10.1016\/j.thromres.2019.07.014_bb0755","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1111\/j.1365-2516.2010.02230.x","article-title":"Prevalence of allo-immunization anti-HLA and anti-integrin \u03b1IIb\u03b23 in Glanzmann Thromboasthenia patients","volume":"16","author":"Santoro","year":"2010","journal-title":"Haemophilia"},{"key":"10.1016\/j.thromres.2019.07.014_bb0760","first-page":"1038","article-title":"The international, prospective Glanzmann Thrombasthenia Registry: treatment and outcomes in surgical intervention","volume":"100","author":"Poon","year":"2015","journal-title":"Haematologica."},{"key":"10.1016\/j.thromres.2019.07.014_bb0765","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.tmrv.2016.01.001","article-title":"New insights into the treatment of Glanzmann thrombasthenia","volume":"30","author":"Poon","year":"2016","journal-title":"Transfus. Med. Rev."},{"key":"10.1016\/j.thromres.2019.07.014_bb0770","doi-asserted-by":"crossref","DOI":"10.1111\/hae.12017","article-title":"Pattern of bleeding and response to therapy in Glanzmann thrombasthenia","volume":"18","author":"Borhany","year":"2012","journal-title":"Haemophilia."},{"key":"10.1016\/j.thromres.2019.07.014_bb0775","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1111\/j.1538-7836.2004.00767.x","article-title":"Prophylactic and therapeutic recombinant factor VIIa administration to patients with Glanzmann\u2019s thrombasthenia: results of an international survey","volume":"2","author":"Poon","year":"2004","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.thromres.2019.07.014_bb0780","doi-asserted-by":"crossref","DOI":"10.1111\/j.1365-2516.2011.02516.x","article-title":"A systematic review of the management and outcomes of pregnancy in Glanzmann thrombasthenia","volume":"17","author":"Siddiq","year":"2011","journal-title":"Haemophilia"},{"key":"10.1016\/j.thromres.2019.07.014_bb0785","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.3324\/haematol.2016.160754","article-title":"Bleeding risk of surgery and its prevention in patients with inherited platelet disorders","volume":"102","author":"Orsini","year":"2017","journal-title":"Haematologica."},{"issue":"Suppl. 4","key":"10.1016\/j.thromres.2019.07.014_bb0790","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/j.1365-2516.2012.02842.x","article-title":"Treatment of inherited platelet disorders","volume":"18","author":"Seligsohn","year":"2012","journal-title":"Haemophilia."},{"key":"10.1016\/j.thromres.2019.07.014_bb0795","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.thromres.2006.10.018","article-title":"Use of recombinant factor VIIa in the management and prophylaxis of bleeding episodes in two patients with Bernard-Soulier syndrome","volume":"120","author":"Hacihanefioglu","year":"2007","journal-title":"Thromb. Res."},{"key":"10.1016\/j.thromres.2019.07.014_bb0800","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1111\/bjh.15409","article-title":"How we treat the platelet glycoprotein defects; Glanzmann thrombasthenia and Bernard Soulier syndrome in children and adults","volume":"182","author":"Grainger","year":"2018","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.thromres.2019.07.014_bb0805","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1111\/j.1365-2141.2010.08191.x","article-title":"Modern management of severe platelet function disorders","volume":"149","author":"Alamelu","year":"2010","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.thromres.2019.07.014_bb0810","doi-asserted-by":"crossref","first-page":"4397","DOI":"10.1182\/blood.V91.12.4397","article-title":"Bernard-Soulier Syndrome","volume":"91","author":"L\u00f3pez","year":"1998","journal-title":"Blood."},{"key":"10.1016\/j.thromres.2019.07.014_bb0815","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1186\/s13023-014-0213-6","article-title":"Functional and molecular characterization of inherited platelet disorders in the Iberian Peninsula: results from a collaborative study","volume":"9","author":"Sanchez-Guiu","year":"2014","journal-title":"Orphanet J Rare Dis."},{"key":"10.1016\/j.thromres.2019.07.014_bb0820","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1111\/j.1365-2516.2009.02137.x","article-title":"Bernard Soulier syndrome in pregnancy: a systematic review","volume":"16","author":"Peitsidis","year":"2010","journal-title":"Haemophilia."},{"key":"10.1016\/j.thromres.2019.07.014_bb0825","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1111\/j.1365-2141.2006.06343.x","article-title":"A review of inherited platelet disorders with guidelines for their management on behalf of the UKHCDO","volume":"135","author":"Bolton-Maggs","year":"2006","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.thromres.2019.07.014_bb0830","doi-asserted-by":"crossref","first-page":"357","DOI":"10.3109\/09537104.2013.819971","article-title":"Complementary effect of fibrinogen and rFVIIa on clotting ex vivo in Bernard-Soulier syndrome and combined use during three deliveries","volume":"25","author":"Palsson","year":"2014","journal-title":"Platelets."},{"key":"10.1016\/j.thromres.2019.07.014_bb0835","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.3324\/haematol.2014.105924","article-title":"Analysis of 339 pregnancies in 181 women with 13 different forms of inherited thrombocytopenia","volume":"99","author":"Noris","year":"2014","journal-title":"Haematologica"},{"key":"10.1016\/j.thromres.2019.07.014_bb0840","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1080\/22201173.2010.10872716","article-title":"The perioperative management of Bernard-Soulier syndrome: a case report and review of the role of perioperative factor VIIa","volume":"16","author":"Rodseth","year":"2014","journal-title":"S Afr J Anaesthesiol Analg."}],"container-title":["Thrombosis Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S004938481930297X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S004938481930297X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T17:48:10Z","timestamp":1758736090000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S004938481930297X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":168,"alternative-id":["S004938481930297X"],"URL":"https:\/\/doi.org\/10.1016\/j.thromres.2019.07.014","relation":{},"ISSN":["0049-3848"],"issn-type":[{"value":"0049-3848","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The use of prophylaxis in the treatment of rare bleeding disorders","name":"articletitle","label":"Article Title"},{"value":"Thrombosis Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.thromres.2019.07.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}